Opportunity

Federal Register #Docket No. 1753

DEA Notice: Chattem Chemicals Application for Bulk Manufacturing of Controlled Substances

Buyer

Drug Enforcement Administration

Posted

August 25, 2026

Respond By

October 26, 2026

Identifier

Docket No. 1753

NAICS

325199, 424210

This opportunity concerns Chattem Chemicals' application to become a registered bulk manufacturer of controlled substances, as announced by the Drug Enforcement Administration (DEA). - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - OEM/Vendor: - Chattem Chemicals - Products/Controlled Substances Requested for Bulk Manufacturing: - Gamma Hydroxybutyric Acid (2010) - Marihuana (7360) (synthetic production only) - Tetrahydrocannabinols (7370) (synthetic production only) - 4-Methoxyamphetamine (7411) - Dihydromorphine (9145) - Amphetamine (1100) - Methamphetamine (1105) - Lisdexamfetamine (1205) - Methylphenidate (1724) - Cocaine (9041) - Codeine (9050) - Dihydrocodeine (9120) - Oxycodone (9143) - Hydromorphone (9150) - Ecgonine (9180) - Hydrocodone (9193) - Levorphanol (9220) - Methadone (9250) - Methadone intermediate (9254) - Morphine (9300) - Oripavine (9330) - Thebaine (9333) - Oxymorphone (9652) - Noroxymorphone (9668) - Alfentanil (9737) - Remifentanil (9739) - Sufentanil (9740) - Tapentadol (9780) - Fentanyl (9801) - 3,4-Methylenedioxy-N-methylcathinone (7540) - Notable Requirements: - Registration is strictly for bulk manufacturing of the listed substances - Synthetic production is specified for Marihuana and Tetrahydrocannabinols - No other activities (such as research or retail distribution) are permitted for these drug codes - Compliance with all local, state, and federal regulations is required - The application is for distribution and sale of bulk manufactured controlled substances

Description

Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). The company plans to bulk manufacture the listed controlled substances to provide pharmaceutical-grade marihuana to facilitate research in compliance with local, state, and federal regulations. No other activities for these drug codes are authorized for this registration. Comments on or objections to the issuance of the proposed registration may be submitted electronically on or before October 26, 2026. Written requests for a hearing on the application may also be filed by this date.

View original listing